Efficacy and long-term adverse effect pattern of lovastatin
- 1 November 1988
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 62 (15) , J28-J34
- https://doi.org/10.1016/0002-9149(88)90004-5
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia: The finnish multicenter studyThe American Journal of Cardiology, 1988
- A Multicenter Comparison of Lovastatin and Cholestyramine Therapy for Severe Primary HypercholesterolemiaPublished by American Medical Association (AMA) ,1988
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Myolysis and Acute Renal Failure in a Heart-Transplant Recipient Receiving LovastatinNew England Journal of Medicine, 1988
- Lovastatin (Mevinolin) in the Treatment of Heterozygous Familial HypercholesterolemiaAnnals of Internal Medicine, 1987
- New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase.Circulation, 1987
- Therapeutic Response to Lovastatin (Mevinolin) in Nonfamilial HypercholesterolemiaJAMA, 1986
- Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemiaThe American Journal of Cardiology, 1986
- Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.Journal of Clinical Investigation, 1984
- Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers.Journal of Clinical Investigation, 1982